Asian patients with non-cystic fibrosis bronchiectasis had a lower annualized exacerbation rate and less lung function ...

The 2025 class of Howard Hughes Medical Institute Freeman Hrabowski Scholars included 30 early-career scientists, one of ...

Risankizumab outperformed vedolizumab in various outcomes, including clinical response at 12 and 52 weeks, among patients ...

In the treatment of cardiometabolic disease, much has changed in the past 20 years, especially with the emergence of novel ...

Of the 2.3 million women diagnosed annually with breast cancer worldwide, research shows more than half report having ...

Lab monkeys thought to have COVID-19, hepatitis C virus and herpes escaped after the transport vehicle carrying them ...

Use of teduglutide appeared safe for patients with short bowel syndrome, with no increased incidence of gastrointestinal ...

Patients with autoimmune and rheumatic diseases who received antiviral therapy for COVID-19 demonstrated reduced incidence of ...

Adult patients with cancer who had adenomas at baseline and immune checkpoint inhibitor-mediated diarrhea and colitis faced a ...

Use of GLP-1 receptor agonists did not appear to affect esophageal function among patients with type 2 diabetes, according to ...

Progressive myopia is a growing issue in every country as near vision demands for children continue to increase. In 1980, ...

A novel tool could reduce the time it takes to diagnose and classify acute leukemias from days to hours through DNA ...